Drug‐receptor dissociation time, new tool for drug research: Receptor binding affinity and drug‐receptor dissociation profiles of serotonin‐S2, Dopamine‐D2, histamine‐H1 antagonists, and opiates

Drug Development Research

Volumn 8, Issue 1-4, 1986, Pages 119-131

  Leysen, Josée E ^a   Gommeren, Walter ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

binding kinetics; brain homogenates; radioligand binding

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALFENTANIL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALTANSERIN; ASTEMIZOLE; BROMPERIDOL; CARFENTANIL; CHLORPROMAZINE; CINANSERIN; CYPROHEPTADINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR; DROPERIDOL; FENTANYL; HALOPERIDOL; HISTAMINE H1 RECEPTOR; KETANSERIN; LEVOCABASTINE; LOFENTANIL; LYSERGIDE; MEPYRAMINE; METHYSERGIDE; MIANSERIN; MORPHINE; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; OXATOMIDE; PIMOZIDE; PIPAMPERONE; RADIOISOTOPE; RITANSERIN; SEROTONIN 2 RECEPTOR; SETOPERONE; SPIPERONE; SUFENTANIL; XYLAMIDINE;

2 [2 (2,6 DIMETHOXYPHENOXY)ETHYLAMINOMETHYL] 1,4 BENZODIOXANE H 3; ANIMAL CELL; BRAIN; CENTRAL NERVOUS SYSTEM; CLONIDINE H 3; DRUG INTERACTION; DRUG RECEPTOR BINDING; GUINEA PIG; HALOPERIDOL H 3; KETANSERIN H 3; MEPYRAMINE H 3; METHODOLOGY; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; SUFENTANIL H 3;

EID: 0022538889     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430080115     Document Type: Article

References (24)

1. Oxatomide: the prototype of a chemical series of compounds, inhibiting both the release and the effects of allergic mediators
2. Serotonin receptor sensitivity after acute and chronic treatment with mianserin
3. 2 receptor. A receptor‐transducer coupling model to explain insurmountable antagonist effects
4. Astemizole in the treatment of seasonal allergic rhinitis
5. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors
6. 3H‐ketanserin recognition sites
7. 2‐serotonergic antagonists
8. Pimozide, a chemically novel, highly potent and orally long acting neuroleptic drug. Part I. The comparative pharmacology of pimozide, haloperico and chlorpromazine
9. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity
10. 1 antagonist, astemizole
11. 2 receptor, application of an original filter method
12. Neuroleptics
13. 2 receptors
14. 3H] Sufentanil, a superior ligand for μ‐opiate receptors: Binding properties and regional distribution in rat brain and spinal cord
15. The dissociation rate of unlabelled drugs from receptor binding sites: Implication for in vitro and in vivo receptor binding studies
16. 2 antagonist
17. 2 receptor binding sites. Binding properties, brain distribution, and functional role
18. Differentiation of opiate and neuroleptic receptor binding in rat brain
19. 2 antagonists: Ritanserin and setoperone
20. 1) antagonists in the rat
21. 1‐antagonist in patiens with allergic conjunctivitis
22. Effect of astemizole on human psychomotor performance
23. A comparison of alfentanil and fentanyl in short operations with special reference to their duration of action and post‐operative respiratory depression